$46.33 -0.75 (%) Abbott Laboratories - NYSE

Mar. 31, 2015 | 04:00 PM

Partner Headlines

  1. Mylan Q4 Earnings, Guidance In Line As Growth Ramps

    IBD | Mar. 2, 2015 | 17:14PM EST
  2. Making Money With Charles Payne: 02/23/15

    FoxBusiness | Feb. 23, 2015 | 18:00PM EST
  3. Drugmaker Mylan Takes Part In Pharma Feeding Frenzy

    IBD | Feb. 23, 2015 | 14:59PM EST
  4. 3 Companies That Could Be Negatively Impacted By Johnson & Johnson Sale Of Cordis

    Benzinga | Feb. 23, 2015 | 13:57PM EST
  5. Pharma M&A: Bristol-Myers, Valeant Make Deals

    IBD | Feb. 23, 2015 | 12:41PM EST
  6. Mason Hawkins Likes Chemtura, Melco Crown; Doesn't Like Berkshire Hathaway

    Benzinga | Feb. 19, 2015 | 14:59PM EST
  7. AbbVie's Q4 Reflects Its Tremendous Growth Potential Going Forward

    GuruFocus | Feb. 4, 2015 | 11:58AM EST
  8. Mylan Makes Deals In Women's Health, Lung Disease

    IBD | Feb. 2, 2015 | 12:48PM EST
  9. Abbott Launches New Options for People with Cataracts in the United States

    Benzinga | Jan. 30, 2015 | 09:02AM EST
  10. Abbott Laboratories

    IBD | Jan. 29, 2015 | 18:38PM EST
  11. Thermo Fisher, Varian, Abbott Up On Earnings Reports

    IBD | Jan. 29, 2015 | 14:39PM EST
  12. Earnings Scheduled For January 29, 2015

    Benzinga | Jan. 29, 2015 | 04:45AM EST
  13. Feeling Good With This Med Company

    GuruFocus | Jan. 20, 2015 | 15:12PM EST
  14. Nestle & Abbott Labs To Benefit From Chinese Demand For Nutritional Products By Selling Senior-Target Products

    Benzinga | Jan. 20, 2015 | 07:42AM EST
  15. #PreMarket Primer: Friday, December 19: U.S. Debates A Response To Sony Hackers

    Benzinga | Dec. 19, 2014 | 08:17AM EST
  16. Analysts See No Sweeter Deal For Volcano

    Benzinga | Dec. 17, 2014 | 15:34PM EST
  17. Philips Buying Volcano To Boost Image-Guided Therapy

    IBD | Dec. 17, 2014 | 11:34AM EST
  18. US Stock Futures Tumble Ahead Of Producer Prices, Consumer Sentiment Data

    Benzinga | Dec. 12, 2014 | 06:52AM EST
  19. Diamond Hill Adds Two Companies to Portfolio in Third Quarter

    GuruFocus | Dec. 11, 2014 | 15:19PM EST
  20. Boston Scientific Lost the First Place in Innovation

    GuruFocus | Dec. 11, 2014 | 14:41PM EST
  21. Top 7 Dividend Aristocrats: The Best of The Best

    GuruFocus | Dec. 10, 2014 | 15:05PM EST
  22. Top 4 NYSE Stocks In The Drugs-Generic Industry With The Highest Profit Margin

    Benzinga | Dec. 9, 2014 | 05:09AM EST
  23. 6 Stocks Giving Investors Potential Dividend Hikes In December

    GuruFocus | Dec. 4, 2014 | 13:05PM EST
  24. Fast Money Picks For December 3: Canadian Pacific, Abbott Labs, BlackBerry And Ford

    Benzinga | Dec. 3, 2014 | 07:47AM EST
  25. Jon Najarian Sees Unusual Options Activity In Abbott Laboratories

    Benzinga | Dec. 3, 2014 | 07:31AM EST
  26. Dividend Aristocrats In Focus Part 45: AbbVie

    GuruFocus | Nov. 24, 2014 | 16:13PM EST
  27. Zoetis 2015 Guidance Misses As Buyout Theories Abound

    IBD | Nov. 18, 2014 | 15:15PM EST
  28. Vipshop Leads 4 Top Stocks With Bolting RS Lines

    IBD | Nov. 18, 2014 | 08:02AM EST
  29. Five Ethical Drugmakers Keep Leadership Positions

    IBD | Nov. 17, 2014 | 18:27PM EST
  30. Benzinga's M&A Chatter for Monday November 17, 2014

    Benzinga | Nov. 17, 2014 | 18:11PM EST
  31. Mylan Rises On Q3 Earnings Beat, Affirms Abbott Deal

    IBD | Oct. 31, 2014 | 11:17AM EST
  32. Top 4 NYSE Stocks In The Medical Appliances & Equipment Industry With The Highest Dividend Yield

    Benzinga | Oct. 31, 2014 | 04:59AM EST
  33. Benzinga's M&A Chatter for Wednesday October 29, 2014

    Benzinga | Oct. 29, 2014 | 20:53PM EST
  34. Benzinga's Top Upgrades

    Benzinga | Oct. 29, 2014 | 09:47AM EST
  35. Deutsche Bank Upgrades Abbott Laboratories To Buy

    Benzinga | Oct. 29, 2014 | 08:34AM EST
  36. Deutsche Bank Upgrades Abbott Laboratories

    Benzinga | Oct. 29, 2014 | 08:33AM EST
  37. Amgen Q3 Earnings Beat Estimates; Guidance Mixed

    IBD | Oct. 27, 2014 | 18:56PM EST
  38. Better Biotechs Don't Satisfy

    IBD | Oct. 22, 2014 | 18:53PM EST
  39. Abbott Laboratories Conference Call Highlights

    Benzinga | Oct. 22, 2014 | 16:59PM EST
  40. Biogen, Thermo Reports Disappoint; Abbott Accelerates

    IBD | Oct. 22, 2014 | 11:18AM EST
  41. UPDATE: Abbott Q3 Earnings Top Street View

    Benzinga | Oct. 22, 2014 | 09:21AM EST
  42. Earnings Scheduled For October 22, 2014

    Benzinga | Oct. 22, 2014 | 05:16AM EST
  43. Keep an Eye on These 7 Stocks, October 22nd, 2014

    Benzinga | Oct. 22, 2014 | 04:04AM EST
  44. Benzinga Weekly Preview: Earnings Season Is In Full Swing

    Benzinga | Oct. 19, 2014 | 10:19AM EST
  45. Making Money With Charles Payne: 10/17/14

    FoxBusiness | Oct. 17, 2014 | 18:00PM EST
  46. AbbVie Rethinking Shire Deal

    IBD | Oct. 15, 2014 | 18:40PM EST
  47. Shire Falls, AbbVie Questioned On Buyout Backtrack

    IBD | Oct. 15, 2014 | 13:11PM EST
  48. Drugmaker M&A Goes On, With Or Without Tax Inversions

    IBD | Oct. 10, 2014 | 17:37PM EST
  49. Screening For Aggressive Buyback Companies

    YCharts | Oct. 8, 2014 | 17:54PM EST
  50. Becton Buyout Of CareFusion Drives Up Both Stocks

    IBD | Oct. 6, 2014 | 11:47AM EST
Trading Center